On February 22, 2023 BioInvent reported its year-end report January 1 – December 31, 2022 (Presentation, BioInvent, FEB 22, 2023, https://www.bioinvent.com/sites/bioinvent/files/pr/20230222-b063fc0d-51a7-495f-8413-79f7771ad6b9-1.pdf?ts=1677049214 [SID1234630378]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!